Affinia Therapeutics

Develops Adeno-associated viruses(AAV) for gene therapy

placeWaltham, Massachusetts, United States calendar_todayFounded 2019 groups64 employees language affiniatx.com

Registered entities

Social engagement

Social engagement: 11.7K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

20 investors on record; lead investors include F-Prime Capital, New Enterprise Associates, EcoR1, Farallon Capital Management.

Investor typeCountShare
Venture capital1155%
Bank & private debt15%
Other / undisclosed840%

Recent activity

30 Jun 2026
Event
Rewriting the Biology of Cardiovascular Disease panel at BIO2026
Coming soon